Testing effectiveness (Phase 2)Study completedNCT02743351
What this trial is testing
Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more
Fate Therapeutics 96